Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-15-007674)

Filing Details

Accession Number:: 0000899243-15-007674
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-11-05 20:38:49
Reporting Period:: 2015-11-03

Filing Date:: 2015-11-05
Accepted Time:: 2015-11-05 20:38:49
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1552451	Myokardia Inc	MYOK	Pharmaceutical Preparations (2834)	455500552

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1413822	Anastasios Gianakakos	C/O Myokardia, Inc. 333 Allerton Avenue South San Francisco CA 94080	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-11-03	1,350	$10.00	482,165	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	204,081	Indirect	Trust

Footnotes

These shares were purchased through a directed share program in connection with the initial public offering of the Issuer.
These shares are held by the Tassos Gianakakos 2015 Annuity Trust, dated September 25, 2015. The Reporting Person as trustee has sole dispositive power over these shares.